0000000000909221

AUTHOR

Tripthi Kamath

showing 1 related works from this author

Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis

2020

medicine.medical_specialtybusiness.industryPirfenidonemedicine.diseaseGastroenterologyIdiopathic pulmonary fibrosischemistry.chemical_compoundchemistryInternal medicinemedicineNintedanibIn patientbusinessmedicine.drugA23. ILD PROGNOSIS AND BIOMARKERS I
researchProduct